The influence of OATP2B1 and atorvastatin on coproporphyrin isomers in rats

Influence of Slco2b1‐knockout and SLCO2B1‐humanization on coproporphyrin I and III levels in rats

(2023) Jonny Kinzi et al.   BRITISH JOURNAL OF PHARMACOLOGY

Relationship of Hemoglobin Level and Plasma Coproporphyrin‐I Concentrations as an Endogenous Probe for Phenotyping OATP1B

(2021) Yosuke Suzuki et al.   CTS-Clinical and Translational Science

OATP2B1 – The underrated member of the organic anion transporting polypeptide family of drug transporters?

(2021) Jonny Kinzi et al.   BIOCHEMICAL PHARMACOLOGY

Differences in transport function of the human and rat orthologue of the Organic Anion Transporting Polypeptide 2B1 (OATP2B1)

(2021) Janine Hussner et al.   Drug Metabolism and Pharmacokinetics

Organic Anion Transporting Polypeptide 2B1 (OATP2B1) Genetic Variants: In Vitro Functional Characterization and Association With Circulating Concentrations of Endogenous Substrates

(2021) Samantha Medwid et al.   Frontiers in Pharmacology

Performance of Plasma Coproporphyrin I and III as OATP1B1 Biomarkers in Humans

(2021) Mikko Neuvonen et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Endogenous Coproporphyrin I and III Are Altered in Multidrug Resistance-Associated Protein 2-Deficient (TR-) Rats

(2020) Jacqueline Bezençon et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Dose‐Dependent Inhibition of OATP1B by Rifampicin in Healthy Volunteers: Comprehensive Evaluation of Candidate Biomarkers and OATP1B Probe Drugs

(2019) Daiki Mori et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Comprehensive Evaluation of the Utility of 20 Endogenous Molecules as Biomarkers of OATP1B Inhibition Compared with Rosuvastatin and Coproporphyrin I

(2018) Shelby Barnett et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Organic anion transporting polypeptide (OATP)-mediated transport of coproporphyrins I and III

(2015) Dallas Bednarczyk et al.   XENOBIOTICA

Targeted Disruption of Murine Organic Anion-Transporting Polypeptide 1b2 (oatp1b2/Slco1b2) Significantly Alters Disposition of Prototypical Drug Substrates Pravastatin and Rifampin

(2008) H. Zaher et al.   MOLECULAR PHARMACOLOGY